Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.050
-0.030 (-1.44%)
At close: Sep 17, 2025, 4:00 PM EDT
1.950
-0.100 (-4.88%)
Pre-market: Sep 18, 2025, 6:07 AM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $192.44 million as of September 18, 2025. Its market cap has increased by 1.47% in one year.
Market Cap
192.44M
Enterprise Value
153.34M
1-Year Change
1.47%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $192.44M, an increase of 53.68%. That is a compound annual growth rate of 3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 195.84M | 18.27% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |